1. Home
  2. COHU vs HRMY Comparison

COHU vs HRMY Comparison

Compare COHU & HRMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cohu Inc.

COHU

Cohu Inc.

HOLD

Current Price

$47.68

Market Cap

1.9B

Sector

Industrials

ML Signal

HOLD

Logo Harmony Biosciences Holdings Inc.

HRMY

Harmony Biosciences Holdings Inc.

HOLD

Current Price

$36.33

Market Cap

2.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
COHU
HRMY
Founded
1947
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Electrical Products
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
2.2B
IPO Year
1994
2020

Fundamental Metrics

Financial Performance
Metric
COHU
HRMY
Price
$47.68
$36.33
Analyst Decision
Strong Buy
Buy
Analyst Count
6
9
Target Price
$40.50
$44.11
AVG Volume (30 Days)
1.0M
856.6K
Earning Date
04-30-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
7.97
EPS
N/A
0.55
Revenue
$452,956,000.00
$868,453,000.00
Revenue This Year
$14.38
$19.75
Revenue Next Year
$19.12
$12.88
P/E Ratio
N/A
$65.47
Revenue Growth
12.74
21.51
52 Week Low
$17.80
$25.52
52 Week High
$74.60
$40.87

Technical Indicators

Market Signals
Indicator
COHU
HRMY
Relative Strength Index (RSI) 38.08 53.78
Support Level $43.64 $35.05
Resistance Level $52.43 $39.07
Average True Range (ATR) 3.54 1.56
MACD -0.88 -0.14
Stochastic Oscillator 6.42 58.35

Price Performance

Historical Comparison
COHU
HRMY

About COHU Cohu Inc.

Cohu Inc is a supplier of semiconductor test and inspection handlers, micro-electro-mechanical system (MEMS) test modules, test contactors, and thermal sub-systems used by semiconductor manufacturers and test subcontractors. The company's products include Semiconductor ATE (Automated Test Equipment), Semiconductor Handlers, Interface Products such as test contactors, probe heads, and probe pins, Spares and Kits, Bare Board PCB Test Systems, and services. It has one reportable segment, Semiconductor Test and Inspection Equipment (Semiconductor Test & Inspection). Geographically, the company generates maximum revenue from the Philippines, followed by Taiwan, China, Malaysia, the United States, Singapore, and the Rest of the world.

About HRMY Harmony Biosciences Holdings Inc.

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company has one reportable segment: rare neurological diseases. Its product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.

Share on Social Networks: